Internal Medicine, Infectious Disease · Tulsa, OK
NPI
1497803209
Since 2007
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
8803 S 101st East Ave, Suite 350
Tulsa, OK, 74133
Phone (918) 615-3750
Groups this clinician bills Medicare through
Medicare paid, 2024
$456K
329,408 services
Medicare patients, 2024
612
Average age 71
Drug cost, 2024
$828K
2,120 prescriptions
Company payments, 2025
$762
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Peter A Okwuasaba was code J0878 (injection, daptomycin, 1 mg), 304,250 times for 22 patients. In total Peter A Okwuasaba billed 329,408 services in 26 codes, and Medicare paid $456K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-07-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0878 Injection, daptomycin, 1 mg | Office | 304,250 | 22 | $0.05 | $14K |
| J2185 Injection, meropenem, 100 mg | Office | 8,250 | 11 | $0.29 | $2,378 |
| J2407 Injection, oritavancin (orbactiv), 10 mg | Office | 1,920 | 14 | $20.58 | $40K |
| 99233 Hospital E&M - Subsequent | Facility | 1,801 | 374 | $79.74 | $144K |
| 99213 Office E&M - Established | Office | 777 | 268 | $58.98 | $46K |
| 96365 Intravenous Infusion, Hydration | Office | 661 | 56 | $40.13 | $27K |
| 99232 Hospital E&M - Subsequent | Facility | 623 | 170 | $52.66 | $33K |
| J1335 Injection, ertapenem sodium, 500 mg | Office | 576 | 16 | $9.15 | $5,268 |
| 99223 Hospital E&M - Initial | Facility | 476 | 390 | $116.24 | $55K |
| 96366 Intravenous Infusion, Hydration | Office | 280 | 26 | $13.26 | $3,712 |
| 99222 Hospital E&M - Initial | Facility | 88 | 84 | $87.08 | $7,663 |
| 99203 Office E&M - New | Office | 86 | 86 | $71.55 | $6,153 |
| 99291 Critical Care E&M | Facility | 19 | 14 | $144.27 | $2,741 |
| 99204 Office E&M - New | Office | 14 | 14 | $107.39 | $1,503 |
By year: 2022 $495K for 513,220 services; 2023 $488K for 328,256 services; 2024 $456K for 329,408 services.
Medicare prescription drug claims, 2024
In 2024, the drug Peter A Okwuasaba prescribed most often to Medicare patients was Daptomycin, with 328 prescriptions and refills. In total Peter A Okwuasaba wrote 2,120 Medicare prescriptions that cost $828K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Daptomycin Generic | 328 | 328 | 78 | $215K |
| Doxycycline Hyclate Generic | 281 | 316 | 93 | $7,256 |
| Meropenem Generic | 239 | 239 | 57 | $37K |
| Ertapenem Ertapenem Sodium | 170 | 170 | 54 | $58K |
| Ceftriaxone Ceftriaxone Sodium | 145 | 145 | 42 | $18K |
| Vancomycin Hcl Generic | 125 | 125 | 40 | $12K |
| Cefepime Hcl Generic | 111 | 111 | 38 | $21K |
| Cefazolin Sodium Generic | 62 | 62 | 15 | $3,120 |
| Rifampin Generic | 59 | 72 | 15 | $6,646 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 48 | 60 | Under 11 | $235K |
| Fluconazole Generic | 41 | 47 | 22 | $729 |
| Levofloxacin Generic | 39 | 42 | 27 | $388 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 38 | 40 | 19 | $790 |
| Ethambutol Hcl Generic | 35 | 45 | Under 11 | $3,285 |
| Azithromycin Generic | 34 | 52 | Under 11 | $1,794 |
Brand drugs: 200 claims; generic drugs: 1,920 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Peter A Okwuasaba $762 ($762 in general payments such as food, travel and fees) from 11 companies. The largest payer was Paratek Pharmaceuticals, Inc. with $141.
| Company | Payments | Amount |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 8 | $141 |
| ViiV Healthcare Company GSK | 7 | $138 |
| Abbvie Inc. ABBV | 6 | $113 |
| Gilead Sciences, Inc. GILD | 5 | $92.44 |
| Merck Sharp & Dohme LLC MRK | 5 | $80.46 |
| EMD Serono, Inc. MRK.DE | 2 | $78.48 |
| Shionogi Inc 4507.T | 2 | $38.81 |
| CorMedix Inc. CRMD | 1 | $27.78 |
| Aimmune Therapeutics, Inc. | 1 | $20.62 |
| Insmed, Inc. INSM | 1 | $16.63 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.